Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.7.49 (
reverse transcriptase
)
31,746
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The cDNA for a membrane-associated
cGMP-dependent protein kinase
(cGK II) was cloned from rat intestine using
reverse transcriptase
PCR and oligonucleotide primers encoding two conserved motifs of known cGMP-dependent protein kinases and subsequently by screening a rat intestine cDNA library. A full-length clone encodes a protein of 761 amino acids with an estimated size of 87 kDa. Sequences of eight peptides from purified pig intestinal mucosa cGK II were found in the derived amino acid sequence of this clone, identifying it as rat intestinal cGK II. Phylogenetic analysis showed that rat intestinal cGK II is less related to mammalian cGK I than to the Drosophila DG1 gene product and most closely related to a recently cloned mouse brain CGKII isoform. Like several other cGK sequences, that of cGK II contained a leucine/isoleucine heptad repeat motif that has been implicated in dimer formation in cGK I. Expression of cGK II cDNA in HEK 293 cells followed by subcellular fractionation revealed cGK II localization in the cell particulate fraction, consistent with the membrane association of endogenous rat cGK II. On Northern blots, the major cGK II poly(A) RNA form was 4.8 kb, with minor forms of 6.2 and 3.1 kb. The cGK II RNA was highly expressed in rat intestinal mucosa and was 20 times less abundant in rat brain and kidney. The localization of endogenous cGK II RNA in rat small intestine was shown by in situ hybridization to be in villous epithelial cells and to some extent in crypt cells.
...
PMID:Cloning, expression, and in situ localization of rat intestinal cGMP-dependent protein kinase II. 793 83
We have shown that
cGMP-dependent protein kinase
(
PKG
) mediates stimulation of L-type calcium current by cGMP in rabbit atrial myocytes. The human atrium may have similar
PKG
-dependent regulation of calcium current. To elucidate the significance of
PKG
in cardiac function, we have isolated human
PKG
type I alpha cDNA (+1 to 2016), determined the nucleotide sequence and analyzed specific expression of
PKG
in human atrium. We obtained full-length cDNA of
PKG
type I alpha from human atrial RNA using
reverse transcriptase
-polymerase chain reaction (RT-PCR). The coding region of human cardiac
PKG
I alpha showed 99.9% homology to previously published human
PKG
I alpha except for base No. 1983. At this position G was substituted for T and this resulted in an amino acid substitution from Leu649 to Phe649. The cloned
PKG
I alpha cDNA was expressed in COS cells and the expressed
PKG
showed cGMP-stimulated
PKG
enzyme activity and immunoreactivity. Ribonuclease protection assay, Western blot analysis, and
PKG
enzyme activity assays in homogenates from human atrial tissue demonstrated the presence of
PKG
mRNA and protein in human atrial tissue. Immunofluorescence staining confirmed that
PKG
is highly expressed in human atrial myocytes. These findings suggest that
PKG
is highly expressed in human atrium and that
PKG
-dependent phosphorylation may be important in regulation of calcium channel activity in human atrial myocytes.
...
PMID:Expression of cGMP-dependent protein kinase in human atrium. 1144 35
Highly active antiretroviral therapy (HAART) works effectively in inhibiting HIV replication in patients. However, the use of nucleoside
reverse transcriptase
inhibitors (NRTIs) often causes side effects of neuropathic pain, and its mechanism remains to be elucidated. Therefore, we aim to explore the mechanism of NRTIs-induced neuropathic pain at the transcriptome level. C57BL/6 J mice were given intraperitoneal injection of zalcitabine (ddC) or saline (control) for 2 weeks, during which the mechanical pain threshold of the mice was detected by von Frey test. Then the L3~L5 spinal segments of the mice were isolated and subsequently used for RNA sequencing (RNA-seq) on the last day of treatment. The mechanical pain threshold of mice given ddC decreased significantly. Compared with the control group, ddC caused significant changes in the expression of 135 genes, of which 66 upregulated and 69 downregulated. Enrichment analysis showed that the functions of these genes are mainly enriched in regulation of transcription, multicellular organism development, and cell differentiation, and the pathway is mainly enriched in the cGMP-
PKG
signaling pathway and AMPK signaling pathway. Furthermore, key genes such as Gabrd, Kcnd3, Npcd, Insr, Lypd6, Scd2, and Mef2d were also identified. These may serve as drug targets for the prevention or treatment of NRTI-induced neuropathic pain.
...
PMID:Identification of Key Genes and Pathways in Mouse Spinal Cord Involved in ddC-Induced Neuropathic Pain by Transcriptome Sequencing. 3281 84